The CDC shooting aftermath
GUNMAN HITS THE CDC — CDC employees across all of the agency's campuses will be teleworking today, agency leadership told employees, according to a partial recording of a staff call obtained by POLITICO, after a gunman shot multiple rounds into four buildings on the agency's main campus in Atlanta on Friday. The agency is also offering administrative leave for employees who had to shelter in place.
The campus saw some facility damage, including broken locks and doors, as law enforcement worked to clear and secure the area, CDC officials said on the call.
Media outlets have reported that the gunman believed the Covid-19 vaccine had made him sick, citing law enforcement. A police officer was killed while responding to the incident, though no CDC staff were harmed.
The agency is conducting a 'full security assessment,' agency Director Susan Monarez said on the call.
'There was a lot that went right, there was a lot that we want to make sure that we put in place so that when you do return, that everyone can feel safe and supported,' Monarez said.
The backlash: Dr. Elizabeth Soda, an infectious disease doctor with the CDC's Center for Emerging and Zoonotic Infectious Diseases, called for Health Secretary Robert F. Kennedy Jr. to resign on Sunday.
'I am enraged at Robert F. Kennedy Jr.,' said Soda, noting she was speaking in her 'own private capacity.' 'As health secretary, his lies are costing people their lives. His dangerous rhetoric is making Americans sicker as scientific decision-making is destroyed.'
Former U.S. Surgeon General Jerome Adams also criticized Kennedy's response, calling it 'tepid' and too slow.
'How you respond to a crisis defines a leader, and quite frankly, Secretary Kennedy has failed in his first major test in this regard,' Adams told CBS's Margaret Brennan on 'Face the Nation.'
Kennedy addressed the incident in a post on social media platform X on Saturday.
'We are actively supporting CDC staff on the ground and across the agency. Public health workers show up every day with purpose — even in moments of grief and uncertainty,' he wrote. He also addressed agency staff in an email sent to CDC employees Saturday.
An HHS spokesperson did not respond to a request for comment.
Background: The Georgia Bureau of Investigation said 30-year-old Patrick Joseph White, of Kennesaw, Georgia, shot at the agency complex.
'He very deeply believed that vaccines had hurt him, and that they were hurting other people,' one of White's neighbors, Nancy Hoalst, told The New York Times on Saturday.
DeKalb County police officer David Rose was shot and killed while responding to the attack. He was 33, had two children, and his wife was pregnant with a third. Monarez noted on the call that the agency is working to set up a donation for Rose's family.
Key context: The shooting comes amid an already tumultuous time for CDC staff. Hundreds of agency employees received termination notices in April, but some were sporadically rehired. The Trump administration has also proposed slashing the agency's budget by roughly half.
Kennedy has repeatedly raised concerns over the Covid vaccine's safety. Since he began leading HHS in February, the CDC has stopped recommending the vaccine for healthy pregnant people and narrowed the recommendations for healthy children.
Kennedy said earlier this week that HHS would halt $500 million in funding for mRNA research, the technology used to create the first Covid vaccines, citing safety concerns. Many public health experts pushed back on that decision.
WELCOME TO MONDAY PULSE. We're closely watching for the second MAHA report this week. Any intel on timing or contents? Send your tips, scoops and feedback to khooper@politico.com and sgardner@politico.com, and follow along @kelhoops and @sophie_gardnerj.
Industry Intel
NEW PLAN FOR INDIRECT COSTS — Academia has a counteroffer in the standoff between the Trump administration and universities over grant funding, POLITICO's Erin Schumaker reports.
The federal government has long provided grantees with funding for administrative and facilities costs on top of research awards. But now, allies of President Donald Trump accuse the schools of using the payments as slush funds to pursue progressive causes like diversity, equity and inclusion.
The universities deny misusing those funds, but to placate Trump, they're proposing the establishment of a more transparent model for recouping overhead costs. Currently, those fees are negotiated separately with each institution and can vary widely.
At stake is more than $4 billion in funding. Losing that money would slow the search for breakthroughs in health and science and enable foreign rivals to catch up, the scientific community says.
A federal district court judge blocked the administration's plan to cap the fees at 15 percent in March, although the administration has appealed.
Charting a new path: 'It's been made extremely clear to us from day one by members of Congress that if we don't do something, somebody else will,' Kelvin Droegemeier, a professor at the University of Illinois at Urbana-Champaign who's spearheading the effort on behalf of a coalition of universities and research institutes, told POLITICO.
'They said continuing forward with the current model is not in the cards. We took it to mean we could help be a part of that change or wait for it to happen,' said Droegemeier, who led the White House Office of Science and Technology Policy during Trump's first term.
The group proposes a Financial Accountability in Research, or FAIR, plan, which would consist of a detailed accounting of indirect project costs and a shorter, simpler fixed percentage of a project's budget for research organizations to recoup facilities and administrative expenses.
The model is designed to show the costs of conducting research so the government and lawmakers can choose what to fund.
What's next: Senate Appropriations Chair Susan Collins (R-Maine), who has protested the administration's cap because it would hurt universities in her state, floated the new model to NIH Director Jay Bhattacharya at a budget hearing in June, calling it 'far fairer' than Trump's flat rate and saying she believed it would 'increase accountability.'
Talks are expected to ramp up when Congress returns from recess next month.
AROUND THE AGENCIES
GUESS WHO'S BACK — The FDA's top vaccine regulator, who was pushed out roughly two weeks ago under pressure from the White House, has been reinstated, POLITICO's David Lim reports.
After Commissioner Marty Makary requested the return of Dr. Vinay Prasad to his job regulating biologics and vaccines, the White House decided the agency could bring him back after reviewing Prasad's past remarks highlighted by far-right provocateur Laura Loomer last month, according to a person familiar with the decision and granted anonymity to discuss the decision.
'At the FDA's request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' HHS spokesperson Andrew Nixon said. HHS declined to answer additional questions about Prasad's reinstatement.
Why it matters: The return of Prasad marks a personnel victory for HHS Secretary Robert F. Kennedy Jr. and Makary, who opposed his dismissal. In the days after Prasad's ouster, Makary told reporters he encouraged Prasad to reconsider his exit from government.
Loomer immediately slammed the decision to rehire Prasad on social media platform X, describing him as a progressive and referring to his past remarks criticizing President Donald Trump.
'In the coming weeks, I will be ramping up my exposes of officials within HHS and FDA so the American people can see more of the pay for play rot themselves and how rabid Trump haters continue to be hired in the Trump administration,' Loomer posted Saturday. 'There are several Senate Confirmation hearings coming up and I have multiple oppo books ready for distribution!'
Sarepta Therapeutics: It's unclear what Prasad's return will mean for Sarepta Therapeutics, which sparred with the FDA center that regulates its Duchenne muscular dystrophy treatment, Elevidys, in the days before he was removed from the job last month.
Industry Intel
THE IMPACT OF KENNEDY'S mRNA MOVE — Messenger RNA technology, and its potential in cancer treatment and prevention, has excited scientists for years. Now, following HHS Secretary Robert F. Kennedy Jr.'s decision to yank half a billion dollars in federal funding for mRNA vaccine projects, researchers and drugmakers worry that potential will be curtailed, POLITICO's Lauren Gardner reports.
Key context: The rapid development and deployment of mRNA vaccines during the pandemic stoked enthusiasm for the technology's potential to revolutionize cancer treatment. The much faster manufacturing process and the mRNA platform's ability to instruct the immune system to attack problem proteins make it possible to custom-tailor therapies to fight a person's unique tumor. Dozens of treatments are being studied or already in the pipeline.
But scientists and industry executives say Kennedy's discouragement of mRNA vaccines for respiratory diseases could dampen investors' enthusiasm for U.S. companies pursuing drug candidates for cancers and rare genetic diseases that have few therapeutic options. And they fear those firms and researchers might decide to move overseas to countries hungry for their expertise — including places like China that could limit Americans' access to treatments developed within their borders.
'If there was a treatment out there for pancreatic cancer but we couldn't get access to it, how would that make you feel if you had a loved one with pancreatic cancer?' said Kate Broderick, chief innovation officer at Maravai LifeSciences, which makes components for drugs and therapies. 'And that is a genuine reality of these cancellations.'
An HHS spokesperson called the industry's assessment of potential fallout from Kennedy's mRNA decisions 'false,' adding that other uses of the technology weren't affected by Tuesday's announcement.
WHAT WE'RE READING
The Wall Street Journal's Liz Essley Whyte reports on how Robert F. Kennedy Jr. is trying to bring MAHA to Alaska.
The Washington Post's Sabrina Malhi reports on growing anti-sunscreen sentiment on social media that's worrying dermatologists.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
5 minutes ago
- Boston Globe
Man fired 180 shots, breaking 150 windows, in CDC attack
The shooter was stopped by CDC security guards before driving to a nearby pharmacy and opening fire late Friday afternoon, a law enforcement official said. The official wasn't authorized to publicly discuss the investigation and spoke on condition of anonymity. The 30-year-old man, Patrick Joseph White, later died, but authorities haven't said whether he was killed by police or killed himself. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up US Health Secretary Robert F. Kennedy Jr. toured the CDC campus on Monday. CDC security pointed out broken windows across multiple buildings, including the main guard booth, according to a Department of Health and Human Services statement. Advertisement HHS Deputy Secretary Jim O'Neill and CDC director Susan Monarez accompanied him, according to the statement. Kennedy also visited the DeKalb County Police Department, where he met with the police chief. Later. He also met privately with the widow of the fallen officer, David Rose. Monarez posted a statement on social media Friday night that said at least four CDC buildings were hit in the attack. Advertisement The extent of the damage became clearer during a weekend CDC leadership meeting. Two CDC employees who were told about what was discussed at the meeting described details to the Associated Press on condition of anonymity because they weren't authorized to reveal the information. Details were also in an agency memo. Building 21, which houses Monarez's office, was hit by the largest number of bullets. CDC officials did not say if her office was hit. CDC employees were advised to work from home this week. Kennedy issued a statement Saturday that said 'no one should face violence while working to protect the health of others,' and that top federal health officials were 'actively supporting CDC staff." He did not speak to the media during his visit Monday. A retired CDC official, Stephan Monroe, said he worried about the long-term impact the attack would have on young scientists' willingness to go to work for the government. 'I'm concerned that this is going to be a generational hit,' said Monroe, speaking to a reporter near the corner where a poster had been set up in honor of Rose. Kennedy was a leader in a national antivaccine movement before President Trump selected him to oversee federal health agencies, and has made false and misleading statements about the safety and effectiveness of COVID-19 shots and other vaccines. Years of false rhetoric about vaccines and public health were bound to 'take a toll on people's mental health,' and 'lead to violence,' said Tim Young, a CDC employee who retired in April. Dr. Jerome Adams, the US surgeon general during Trump's first administration, said Sunday that health leaders should appreciate the weight of their words. Advertisement 'We have to understand people are listening,' Adams told 'Face the Nation' on CBS. 'When you make claims that have been proven false time and time again about safety and efficacy of vaccines, that can cause unintended consequences.'
Scientific American
35 minutes ago
- Scientific American
How the New Chikungunya Virus Outbreak in China Could Reach the U.S.
Thousands of cases of the chikungunya virus, which sickens people bitten by an infected mosquito, have broken out in China during the past week. The virus causes extremely severe joint pain and fever, both of which can be short-lived—but can sometimes continue for years. Chikungunya can sometimes cause heart damage. Three days ago, the U.S. Centers for Disease Control and Prevention issued a travel warning for the area of the outbreak (the province of Guangdong in southern China), advising people to take precautions. And experts warn that chikungunya could further spread in the Americas and parts of Europe, though cases there have been relatively rare compared with those in tropical regions. Here is what you need to know about the disease and the risk. What is the chikungunya virus, and how do people get infected? The virus was first identified in Africa in 1952. It is spread most often by two mosquito species: Aedes aegypti and Aedes albopictus. People can get sick within three to seven days of a bite. In 2025 about 240,000 cases and 90 deaths have been reported in 16 countries and territories through July. Cases have been reported in the Americas, Africa, Asia and Europe. Infection usually produces symptoms including deeply painful joints, fevers, nausea, fatigue and a rash. Most of the time these problems resolve in a week or two. 'But sometimes they can continue for months and years, and the virus can also cause serious heart damage,' says Jean Lim, a microbiologist at the Icahn School of Medicine at Mount Sinai and a member of the Global Virus Network's chikungunya task force. 'In rare cases it can be fatal, and those most vulnerable are people who are immunocompromised, the elderly, and babies.' On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. What has happened in China? China has reported an outbreak with about 7,000 cases, mostly in Guangdong and its city of Foshan. The Chinese government has distributed mosquito nets and sprayed insecticide through residential areas, streets and places where people work outside. There have been reports that authorities have forced infected people into hospitals, reminding some of the strict measures China took during the COVID pandemic. It remains unclear what triggered the outbreak, says Robert Jones, an insect biologist at the London School of Hygiene &Tropical Medicine and another member of the Global Virus Network's task force. But several weeks of rain and high humidity in the area have created good conditions for A. aegypti and A. albopictus to breed and bite more people, he notes. Can the virus get from China to the U.S.? Chikungunya moves easily in this age of fast global travel. There are current outbreaks in France and a case reported in Italy, Jones says. The most likely scenario, according to Lim, is that 'a mosquito in China bites and infects someone. That person hops on a plane and flies to the U.S. There a U.S. mosquito bites that person and picks up the virus, and then begins to spread it through the local insect population.' For this to happen, the new country needs to already have mosquitoes that can host the virus. 'Neither of these species is established in the UK, so there is no risk of onward transmission,' Jones says. But 'in the United States, both Aedes aegypti and Aedes albopictus can be found, particularly in the south and east. To date there have been 47 cases of chikungunya confirmed in the U.S. this year.' Still, there are limiting factors that should minimize worry, says William Klimstra, an immunologist at the University of Pittsburgh's Center for Vaccine Research. Spraying insecticide and eliminating mosquito breeding areas are effective ways to curb outbreaks. And in a temperate area, the first killing frost will get rid of the insects, stopping viral transmission. Are there treatments or vaccines for the virus? Unfortunately, there are no good antiviral therapies, Lim says. Treatment usually consists of supportive care, such as keeping a patient hydrated and managing their pain. There are, however, two effective and Food and Drug Administration–approved vaccines that get the body to produce antibodies against chikungunya, Jones says, and these lower the risk of infection. One, called IXCHIQ, uses a weakened, noninfective form of the virus. The other vaccine, VIMKUNYA, is based on viruslike particles. And fortunately, insect repellents and protective clothing work quite well to keep the biting mosquitoes away in outbreak-prone regions of the world.
The Hill
35 minutes ago
- The Hill
Kennedy visits CDC after deadly shooting
In a statement, HHS said CDC security led Kennedy on a tour of the campus, pointing out shattered windows across multiple buildings, including the main guard booth. CDC Director Susan Monarez said four buildings were hit, and more than 40 bullets smashed through office windows. DeKalb County Police Officer David Rose was mortally wounded while responding to Friday's shooting. Most CDC personnel assigned to the campus are teleworking this week, and additional safety and security measures are being put in place ahead of their return, according to HHS. In a statement posted on X on Saturday, Kennedy said the agency was 'deeply saddened' by the shooting. 'We know how shaken our public health colleagues feel today. No one should face violence while working to protect the health of others,' Kennedy said. Multiple reports have said the suspect in the shooting was fixated on the COVID-19 vaccine and blamed it for his mental health issues. Kennedy, who founded an anti-vaccine group before becoming HHS Secretary, has also long disparaged the CDC and public health officials. He once called the agency a 'cesspool of corruption' while running for president. Under his leadership, the Trump administration has laid off nearly 2,000 employees. CDC and public health officials have been subject to increased anti-vaccine backlash fueled by conspiracy theories, as well as blowback to public health measures implemented in response to the coronavirus pandemic. The union that represents CDC employees said disinformation about vaccines has put workers' safety at risk and called on HHS to condemn the spread of false information about vaccines and protect employees from future violent threats.
